Schonfeld Strategic Advisors LLC Procept Bio Robotics Corp Transaction History
Schonfeld Strategic Advisors LLC
- $13.8 Billion
- Q3 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 5,336 shares of PRCT stock, worth $499,449. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,336
Previous 6,000
11.07%
Holding current value
$499,449
Previous $366,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PRCT
# of Institutions
266Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$453 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$326 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$144 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$116 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$110 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $4.17B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...